MedTrace Logo

Efficiency of PRGF-Endoret in Combination With a Bone Graft in Lateral Sinus Floor Elevation

NCT01771302 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2021-08-23

No results posted yet for this study

Summary

This randomized clinical study investigates the efficiency of plasma rich in growth factors (PRGF-Endoret) in combination with bone grafts in the healing of bone and soft tissues after the performance of lateral sinus floor elevation.

The hypothesis of this study is that the use of PRGF-Endoret will produce similar bone formation regardless the type of bone graft.

Conditions

  • Sinus Floor Augmentation

Interventions

DEVICE

Bio-Oss

It is a bone substitute of bovine origin

DEVICE

calcium phosphate ceramic

It is a synthetic bone substitute ceramic that is composed of calcium and phosphate ions and prepared at high temperature

Sponsors & Collaborators

  • Biotechnology Institute IMASD

    collaborator INDUSTRY

  • Fundación Eduardo Anitua

    lead OTHER

Principal Investigators

  • Eduardo Anitua, MD, DDS, PhD · Clinica Eduardo Anitua

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2014-04-30
Completion
2014-04-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01771302 on ClinicalTrials.gov